Stockscreener 앱 받기
5.65
0.00%
0.00
시간 외 거래:
5.67
0.02
+0.35%
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
Abeona Therapeutics director Christine Silverstein sells $103,695 in stock By Investing.com - Investing.com Australia
Abeona Therapeutics (ABEO) director sells 18,160 shares to cover tax - Stock Titan
[144] ABEONA THERAPEUTICS INC. SEC Filing - Stock Titan
Abeona Therapeutics Inc. (ABEO) 8-K Filing June 12, 2026: Submission of Matters to a Vote of Security Holders - Minichart
Abeona Therapeutics (ABEO) investors approve equity plan boost, keep director notice rule - Stock Titan
ABEO: All proposals passed except the advance notice provision amendment for director nominations - TradingView
Abeona Therapeutics Inc. Announces Resignation of Michael Amoroso as Member of Board of Directors, Nominating and Corporate Governance Committee, Effective June 11, 2026 - marketscreener.com
Michael Amoroso resigns from Abeona board and nominating committee - TradingView
Abeona (NASDAQ: ABEO) director Michael Amoroso steps down from board - Stock Titan
Updated Abeona Therapeutics (NASDAQ: ABEO) investor presentation furnished in 8-K filing - Stock Titan
Abeona Therapeutics CFO Joseph Vazzano sells $265,242 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $51,548 in shares. - Investing.com UK
Abeona Therapeutics CEO sells $301,920 in stock By Investing.com - Investing.com South Africa
Abeona Therapeutics CCO Vasanthavada Madhav sells $51,548 in shares. By Investing.com - Investing.com Nigeria
Abeona Therapeutics SVP, chief legal officer sells $59,645 in stock - Investing.com UK
Abeona Therapeutics CEO sells $301,920 in stock - Investing.com India
Abeona Therapeutics SVP, chief legal officer sells $59,645 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CFO Joseph Vazzano sells $265,242 in stock - Investing.com
[Form 4] ABEONA THERAPEUTICS INC. Insider Trading Activity - Stock Titan
Abeona Therapeutics (ABEO) CFO sells 49,338 shares under 10b5-1 tax plan - Stock Titan
(ABEO) Volatility Zones as Tactical Triggers - Stock Traders Daily
ABEO (NASDAQ: ABEO) insider sales: 13,421 shares reported, plus 785-share sale - Stock Titan
ABEO (NASDAQ: ABEO) notice: proposed resale of 10,000 shares via Stifel - Stock Titan
ABEO (NASDAQ: ABEO) files Form 144 to sell 112,276 compensation shares - Stock Titan
Proposed resale notice — ABEO (Nasdaq: ABEO) lists 25,000 shares - Stock Titan
Abeona Advances ABO-701 T-Cell Therapy Toward IND - The Globe and Mail
Abeona Therapeutics reports constructive Pre-IND meeting with FDA on ABO-701, IND targeted for 2027 - TradingView
Abeona Therapeutics (ABEO) details FDA Pre-IND meeting and 2027 IND goal for ABO-701 - Stock Titan
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Price-Driven Insight from (ABEO) for Rule-Based Strategy - Stock Traders Daily
ABEO Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20 - GuruFocus
H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Abeona Therapeutics (ABEO) director reports bona fide 500-share gift - Stock Titan
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - The Manila Times
Abeona plans Jefferies fireside chat, Goldman investor meetings - Stock Titan
ABEOAbeona Therapeutics Inc Stock Price and Quote - Finviz
Lightning eMotors Inc. (ZEV) - Minichart
Abeona Therapeutics director Mark Alvino sells $35,462 in stock By Investing.com - Investing.com India
Insider Sell: Mark Alvino Sells 6,500 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus
Abeona Therapeutics director Mark Alvino sells $35,462 in stock - Investing.com UK
Abeona Therapeutics (ABEO) director sells 6,500 shares in open-market trade - Stock Titan
May 2026's Top Insider-Owned Growth Companies - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Abeona Therapeutics (NASDAQ: ABEO) Reports $8.7 Million in Q1 Revenue as ZEVASKYN Adoption Accelerates - foreignpolicyjournal.com
Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum - TipRanks
Daily Brief Health Care: Dermavon Holdings, Alebund Pharmaceuticals Jiangsu, Alnylam Pharmaceuticals, Artrya , Bavarian Nordic A/S, Cardinal Health, Dexcom Inc, American Shared Hospital Servi, Eli Lilly & Co, Abeona Therapeutics and more - Smartkarma
(ABEO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ABEO: Three Patients Treated in 1Q26 with Two Additional QTCs Activated - Zacks Small Cap Research
Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips - Investing.com
2.60%
0.94%
자본화:
|
볼륨(24시간):